Similar Papers

Paper Title
Journal
Date
Author
Prognostic impact of systemic anti-cancer therapy on patients with advanced cancer at end of life: Analysis of a multicenter prospective cohort study using propensity score methods.
Shuji Hiramoto ... Hori Tetsuo
Journal of Clinical Oncology | VOL. 40
Shuji Hiramoto, et. al.Shuji Hiramoto ... Hori Tetsuo
01 Jun 2022
Real World Data – Does it Cut the Mustard or Should We Take it With a Pinch of Salt?
R Muirhead ... A Aggarwal
Clinical Oncology | VOL. 35
R Muirhead, et. al.R Muirhead ... A Aggarwal
19 Oct 2022
Systemic anti-cancer therapy and cost at end of life: A SEER Medicare analysis.
Kerin B Adelson ... Maureen Canavan
Journal of Clinical Oncology | VOL. 42
Kerin B Adelson, et. al.Kerin B Adelson ... Maureen Canavan
01 Jun 2024
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
S Popat ... M Reck
Annals of Oncology | VOL. 33
S Popat, et. al.S Popat ... M Reck
30 Nov 2021
View more papers

More From: Lung Cancer

Paper Title
Journal
Date
Author
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies
Hiroaki Akamatsu ... Tetsuya Mitsudomi
Lung Cancer | VOL. -
Hiroaki Akamatsu, et. al.Hiroaki Akamatsu ... Tetsuya Mitsudomi
01 Feb 2025
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer
Joaquim Bosch-Barrera ... Teresa Morán
Lung Cancer | VOL. -
Joaquim Bosch-Barrera, et. al.Joaquim Bosch-Barrera ... Teresa Morán
01 Feb 2025
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK+ NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials
D Ross Camidge ... Sanjay Popat
Lung Cancer | VOL. -
D Ross Camidge, et. al.D Ross Camidge ... Sanjay Popat
01 Feb 2025
Exercise medicine for individuals diagnosed with Lung Cancer: A systematic review and meta-analysis of health outcomes
Salvatore Ficarra ... Christina M Dieli-Conwright
Lung Cancer | VOL. -
Salvatore Ficarra, et. al.Salvatore Ficarra ... Christina M Dieli-Conwright
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.